Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Grifois, S.A. (GRFS)

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/02/2011

Market Cap

5,776,334,699

Shares Outstanding

261,430,000

Weighted SO

678,410,694

Total Employees

N/A

Upcoming Earnings

07/25/2024

Similar Tickers

NVS --.--%

AZN --.--%

GSK --.--%

RHHBY --.--%

BMY --.--%

MRK --.--%

GILD --.--%

AMGN --.--%

BIIB --.--%

Beta

0.6990

Last Div

0.0000

Range

5.3-12.15

Chg

0.2050

Avg Vol

1459793

Mkt Cap

5776334699

Exch

NASDAQ

Country

ES

Phone

34 93 571 02 21

DCF Diff

5.3509

DCF

1.7941

Div Yield

0.0000

P/S

0.7703

EV Multiple

10.6420

P/FV

0.7908

Div Yield %

0.0000

P/E

29.1343

PEG

4.0543

Payout

0.0000

Current Ratio

1.6817

Quick Ratio

0.8005

Cash Ratio

0.5139

DSO

50.1083

DIO

313.4036

Op Cycle

363.5119

DPO

75.9205

CCC

287.5914

Gross Margin

0.3804

Op Margin

0.1421

Pretax Margin

0.0357

Net Margin

0.0223

Eff Tax Rate

0.4120

ROA

0.0068

ROE

0.0258

ROCE

0.0532

NI/EBT

0.6240

EBT/EBIT

0.2513

EBIT/Rev

0.1421

Debt Ratio

0.4313

D/E

1.7191

LT Debt/Cap

0.5537

Total Debt/Cap

0.6322

Int Coverage

1.9959

CF/Debt

0.0416

Equity Multi

3.9858

Rec Turnover

7.2842

Pay Turnover

4.8077

Inv Turnover

1.1646

FA Turnover

1.6160

Asset Turnover

0.3055

OCF/Share

0.5885

FCF/Share

0.2385

Cash/Share

3.3247

OCF/Sales

0.0587

FCF/OCF

0.4052

CF Coverage

0.0416

ST Coverage

0.1495

CapEx Coverage

1.6813

Div&CapEx Cov

1.6813

P/BV

0.7908

P/B

0.7908

P/S

0.7703

P/E

29.1343

P/FCF

32.3672

P/OCF

11.0574

P/CF

11.0574

PEG

4.0543

P/S

0.7703

EV Multiple

10.6420

P/FV

0.7908

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 10, 09:39 Blood-plasma group’s shares rally after short seller slashes negative bet MarketWatch Jan 09, 08:24 Spanish blood plasma company stock tumbles after short-seller research report GlobeNewswire Inc. Oct 24, 18:30 Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.44 06/03/2021 05/26/2021 06/04/2021 06/14/2021
0.20 10/30/2020 10/22/2020 11/02/2020 11/09/2020
0.22 12/02/2019 10/31/2019 12/03/2019 12/11/2019
0.17 06/07/2019 05/29/2019 06/10/2019 06/18/2019
0.23 11/30/2018 11/07/2018 12/03/2018 12/11/2018
0.25 06/01/2018 05/25/2018 06/04/2018 06/12/2018
0.21 12/01/2017 11/30/-0001 12/04/2017 12/12/2017
0.16 05/30/2017 05/26/2017 06/01/2017 06/08/2017
0.19 12/05/2016 11/22/2016 12/07/2016 12/14/2016
0.16 06/02/2016 05/31/2016 06/06/2016 06/15/2016
0.37 12/10/2015 12/01/2015 12/14/2015 12/17/2015
0.34 06/08/2015 11/30/-0001 11/30/-0001 06/15/2015
0.31 12/04/2014 11/30/-0001 11/30/-0001 12/12/2014
0.29 06/05/2014 11/30/-0001 11/30/-0001 06/13/2014
0.26 06/05/2013 11/30/-0001 11/30/-0001 06/13/2013
0.01 05/29/2013 11/30/-0001 11/30/-0001 11/30/-0001